HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tim Attmann Andreas Boening Jochen Cremer Georg Lutter Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quaden, R. Articles by Lutter, G. Search for Related Content PubMed PubMed Citation Articles by Quaden, R. Articles by Lutter, G. Related Collections Minimally invasive surgery Valve disease

Eur J Cardiothorac Surg 2005;27:836-840
© 2005 Elsevier Science NL

Percutaneous aortic valve replacement: resection before implantation

Department of Cardiovascular Surgery, School of Medicine, Christian-Albrechts-University of Kiel, Arnold-Heller-Strasse 7, D-24105 Kiel, Germany

Received 4 September 2004; received in revised form 2 January 2005; accepted 12 January 2005.

^* Corresponding author. Tel.: +49 431 597 4582; fax: +49 431 597 4402. (E-mail: lutter{at}kielheart.uni-kiel.de).

Objective: After transluminal endovascular implantation of a new valved stent, the aim of this study was to evaluate the feasibility of using a high-pressure water stream to endovascularly resect human calcified aortic valves. Methods: First, human calcified aortic valves were excised and then resected in vitro to determine optimal water jet parameters. Second, healthy porcine aortic valves were ablated in vitro to evaluate possible destruction to the surrounding anatomy. Third, resection was performed endoluminally by introducing microsystemic tools into the descending aorta, passing them through the arch and ascending aorta to the aortic valve in an in vitro porcine model. Macro- and micropathology of specimens were analyzed. Results: First, resection of human calcified valves took a mean of 6.0±2.4min per three leaflets at 150bar (n=17). The maximum size of the cut leaflets was 7.1±1.7mm. Second, resection of healthy porcine aortic valves at 60bar took 2.3±0.3min per three leaflets (n=10). Only the aortic annulus was moderately affected in six cases. Third, endoluminal resection via the descending aorta took 12.2±0.8min per three leaflets at 60bar (n=10). The aortic wall was affected in four cases, the aortic annulus and the coronary ostia only once. Microscopic analysis also revealed superficial lesions with a maximum lesion depth of 1200µm in one case, and an average of 580±145µm in subsequent lesions. The mitral valve and the left ventricular outflow tract were not affected. Conclusions: Percutaneous resection of heart valves is emerging as a promising auxiliary method for the resection of calcified aortic heart valves because they can be cut endoscopically. Nonetheless, before this resection tool can be clinically applied by surgeons to perform a true percutaneous valve replacement, an additional aortic valve resection chamber (already at the prototype stage) designed for capturing all debris, has to be established.

Key Words: Resection • Excision • Percutaneous valve replacement • Aortic valve • Endovascular • Transluminal

This article has been cited by other articles:

				S. Salizzoni, P. Bajona, K. J. Zehr, W. D. Anderson, S. Vandenberghe, and G. Speziali Transapical off-pump removal of the native aortic valve: a proof-of-concept animal study. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 468 - 473. [Abstract] [Full Text] [PDF]

				D. Wendt, W. Muller, F. Hauck, M. Thielmann, H. Wendt, B. Kipfmuller, B. Vogel, and H. Jakob In vitro results of a new minimally invasive aortic valve resecting tool Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 622 - 627. [Abstract] [Full Text] [PDF]

				R. Quaden, T. Attmann, M. Schunke, D. Theisen-Kunde, J. Cremer, and G. Lutter Percutaneous aortic valve replacement: Endovascular resection of human aortic valves in situ. J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1081 - 1086. [Abstract] [Full Text] [PDF]

				D. Wendt, M. Thielmann, T. Buck, R.-A. Janosi, T. Bossert, N. Pizanis, M. Kamler, and H. Jakob First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 542 - 547. [Abstract] [Full Text] [PDF]

				E. M. Flecher, J. W. Curry, T. M. Joudinaud, C. L. Kegel, P. A. Weber, and C. M.G. Duran Coronary flow obstruction in percutaneous aortic valve replacement. An in vitro study Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 291 - 294. [Abstract] [Full Text] [PDF]

				R. Quaden and G. Lutter Editorial comment: Resection and new stents before valved stent implantation Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 295 - 295. [Full Text] [PDF]

				T. Walther, V. Falk, M. A. Borger, T. Dewey, G. Wimmer-Greinecker, G. Schuler, M. Mack, and F. W. Mohr Minimally invasive transapical beating heart aortic valve implantation -- proof of concept Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 9 - 15. [Abstract] [Full Text] [PDF]

				T. Walther, T. Dewey, G. Wimmer-Greinecker, M. Doss, R. Hambrecht, G. Schuler, F. W. Mohr, and M. Mack Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 703 - 708. [Abstract] [Full Text] [PDF]

				T. Attmann, T. Jahnke, R. Quaden, A. Boening, S. Muller-Hulsbeck, J. Cremer, and G. Lutter Advances in Experimental Percutaneous Pulmonary Valve Replacement Ann. Thorac. Surg., September 1, 2005; 80(3): 969 - 975. [Abstract] [Full Text] [PDF]